Research and Innovation

Ongoing research and innovation targets personalised medicine, evidence from artificial intelligence and the final ecosystem steps: more efficient dissemination, adaptation and implementation to demonstrate a true impact on patient care. Here are some of our ongoing projects.

BMJ RapidRecs

Providing clinicians and patients with trustworthy recommendations and evidence summaries for potentially practice changing evidence. A project in collaboration with the BMJ.

More info: contact Thomas@magicevidence.org

Living guidelines

Our online authoring and publication platform MAGICapp was created to solve key problems with clinical practice guidelines, including making guidelines living. There are several living guidelines from various organisations in MAGICapp, and we participate in development of some of these.

More info: contact Per@magicevidence.org

GELA

The Global Evidence, Local Adaptation (GELA) project increase the impact of research on poverty-related diseases through a programme of improving decision makers’ capacity to use global research to develop locally relevant guidelines for newborn and child health.

More info: contact tandi@magicevidence.org

ReMeDy

Aiming to improve the evidence ecosystem for rheumatic and musculoskeletal diseases in Norway and beyond.

More info: contact leticia@magicevidence.org

BE-SAFE

Aiming to improve patient safety and quality of care through patient-centred and evidence-based interventions to reduce benzodiazepine and sedative hypnotic use.

More info: contact Stijn@magicevidence.org

OperA

The Optimising Colorectal Cancer Prevention Trough Personalised Treatment with Artificial Intelligence project (OperA) aims to reduce the incidence and mortality of colorectal cancer through AI-enhanced screening.

MATCH-IT

An interactive decision support tool for multiple treatment choices.

For more info: contact PerOlav@magicevidence.org

Evidence Ecosystem (E3)

Digital and trustworthy personalised eHealth solutions to increase value and reduce waste in the current health care ecosystem.

For more info: contact siri@magicevidence.org

Gateway

MAGIC is supporting WHO in enhancing the dissemination, adaptation and translation of living WHO COVID-19 guidelines for member states.

For more info, contact. stijn@magicevidence.org

Decision Aids

Linked to GRADE Guidelines to improve Shared-Decision Making in the clinical encounter.

More info: contact Thomas@magicevidence.org

Clinical Decision Support

Guideline recommendations as decision support in electronic medical records, linked to patient data.

For more info, contact. linn@magicevidence.org

HTA

Our initiative in the research and innovation phase for the development of Health Technology Assessments.

For more info, contact. stijn@magicevidence.org

Adaptation Strategies

Novel Adaptation Process and Taxonomy for modifying individual guideline recommendations.

For more info: contact per@magicevidence.org

MARC-SE

The MARC SE-Africa project is designed to promote the translation of evidence of artemisinin and other drug resistance of public health significance to inform better malaria policy and practice before drug resistance increases the number of malaria cases and deaths.

For more info: contact prashanti@magicevidence.org